FDA Converts Novel Alzheimer’s Disease Treatment to Traditional Approval
The U.S. Food and Drug Administration converted Leqembi (lecanemab-irmb), indicated to treat adult patients with Alzheimer’s Disease, to traditional approval following a determination that a confirmatory trial verified clinical benefit. Leqembi is the first amyloid...Frequently asked questions about the newly approved Alzheimer’s drug, Aduhelm™ (aducanumab)
Printable PDF Is this drug a cure for Alzheimer’s disease? No. This medication, marketed under the name Aduhelm™, is not a cure. It does not reverse damage already caused by Alzheimer’s disease, nor does it completely stop the disease. Aducanumab works to slow the...Interested in volunteering for research on Alzheimer’s, related dementias, and cognitive health?
Alzheimer’s Prevention Registry Get information and updates about participating in future Alzheimer’s prevention trials. Alzheimer’s Prevention Registry » Alzheimer’s Prevention Trials (APT) Webstudy Enroll to track memory and thinking skills, and...NIA Launches New Website
NIA is pleased to announce www.Alzheimers.gov, a new website designed to educate and support people whose lives are touched by Alzheimer’s disease and related dementias. The website serves as a federal government portal for dementia information and resources.Caregiving in a time of Coronavirus: A message from your Alzheimer’s Disease Research Center
We are addressing this to all the family members and friends who provide care for persons living with Alzheimer’s disease and similar dementias. The care you provide is always vital to the quality of life and well-being of that person. The Novel Coronavirus (COVID-19)...Local Researchers Focusing on Alzheimer’s Disease Prevention
Alzheimer’s disease impacts nearly 6 million Americans. Researchers at the University of Pittsburgh are working to try and figure out why and whether it can be stopped. They say it may start with a walk around the block.
Dr. Jennifer Lingler and Niki Kapsambelis talk about Alzheimer’s disease on KDKA TV
What do we know about AD and how do we treat it? Dr. Jennifer Lingler and Niki Kapsambelis talk to Ken Rice and Sally Stapleton on KD/PG Sunday edition.
WQED Documentary “Stolen Years” Highlights Research Being Conducted at the University of Pittsburgh ADRC
Nearly two-thirds of Americans living with Alzheimer’s are women. Sixty percent of all Alzheimer’s caregivers are women.
ADRC Neurologist, Dr. Riddhi Patira weighs in on what Causes Alzheimer’s. We Don’t Really Know Yet.
In an online article in Live Science staff writer Yasemin Saplakoglu discusses a recent study suggesting a possible cause of Alzheimer’s disease.
BRiTE Wellness Program aims to help seniors with mild memory problems
The BRiTE (Brain Training and Exercise) Center mission is to promote the overall health and wellness of older adults who want to optimize their level of cognitive, social, and physical functioning.
Dr. Annie Cohen & Melita Terry discuss African American recruitment efforts in Alzheimer’s Disease research
Melita Terry, Alzheimer’s Disease Research Center Outreach Coordinator and Dr. Annie Cohen, Assistant Professor of Psychiatry, both at the University of Pittsburgh, spoke about Alzheimer’s disease at the Urban League Lunch and Learn in February, 2018.
Pitt Researchers try to determine why Black community hit hardest by Alzheimer’s disease
A recent article in the Pittsburgh Courier says: It is well known that Alzheimer’s disease is the most common form of dementia. Dementia describes symptoms of memory loss and other cognitive abilities that are serious enough to affect daily life.
Dr. James Becker comments about alcohol and longevity
Could a daily drinking habit be the secret to a long life? Mary Brophy Marcus of Men’s Health magazine talks to the experts.
Dr. William Klunk and Dr. Oscar Lopez take part in Brain Day 2017 at the University of Pittsburgh’s Brain Institute
Brain Day is an all-day event that brings together experts from around Pitt to share their work in neuroscience with not only their colleagues, but with the patient advocacy community.
Press Release: New NIH consortium award to enhance clinical trials for Alzheimer’s disease, related dementias
A new clinical trials consortium funded by the National Institutes of Health is expected to accelerate and expand studies for therapies in Alzheimer’s disease and related dementias.
Distinct Cognitive Fates in the Very Old
While many studies have tracked the mental abilities of healthy people who test positive for Alzheimer’s biomarkers, few have examined the very old over the long term.
Bill Gates plans to donate $50 million to Alzheimer’s Disease Research
Bill Gates spoke with CNN Chief Medical Correspondent, Dr. Sanjay Gupta about why he plans on donating $50 million of his own money to the Dementia Discovery Fund.
Pitt Researcher Jennifer Lingler, PhD awarded $2.6 million NIH grant to study Racial Disparities in Alzheimer’s Disease
Dr. Jennifer Lingler awarded $2.6 million by the National Institutes of Health to conduct a study addressing racial disparities in Alzheimer’s disease research.
Research offers no sure-fire way to prevent cognitive decline
Gary Rothstein of the Pittsburgh Post-Gazette reports on the release of a comprehensive report that analyzed how people might be able to prevent dementia.
Discussing Alzheimer’s Research with Dr. William Klunk on NPR
Dr. William Klunk joined Niki Kapsambelis on an interview with Liz Reid on WESA 90.5, Pittsburgh’s NPR News Station to discuss Alzheimer research in early April.
Seniors Dance, Paint and Stretch to Fight Memory Loss in New Pitt Program
Pittsburgh Seniors use music, art, yoga and more at the University of Pittsburgh’s new Brain Exercise and Training Program or BRiTE.
New Blood Test Aids Pitt Alzheimer’s Research
With a new blood test, Pitt researchers are hoping to determine whether the content of someone’s blood could indicate if their learning and memory abilities are in danger of diminishing.
Longstanding Family of Pitt Research Participants Featured in New Book
Eight years ago Niki Kapsambelis wrote a feature in the ADRC Fall Newsletter about the DeMoe family, a family of ADRC research participants with a rare genetic version of Alzheimer’s Disease.
$500,000 Joseph & Ligia Wiegand Family Foundation Endowment Received for Pitt’s Day of Giving
ADRC receives $500,000 endowment from the Joseph & Ligia Wiegand Family Foundation
